The association between body mass index groups and metabolic comorbidities with healthcare and medication costs: a nationwide biobank and registry study in Finland

Aino Vesikansa,Juha Mehtälä,Katja Mutanen,Annamari Lundqvist,Tiina Laatikainen,Tero Ylisaukko-oja,Tero Saukkonen,Kirsi H. Pietiläinen

Journal of Market Access & Health Policy（2023）

引用 1|浏览8

暂无评分

摘要

To manage the cost burden of obesity, treatment should be given equal consideration as other chronic diseases, and BMIs ≥30.0 kg/m should be considered in treatment decisions.

查看译文

关键词

Body mass index,comorbidities,direct costs,healthcare costs,medication costs,metabolic syndrome,obesity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要